2023 Q1 Form 10-Q Financial Statement

#000188584923000004 Filed on March 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $3.850K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.00K $0.00
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $9.413K $5.322K
YoY Change 76.87%
Operating Profit $5.563K $5.322K
YoY Change 4.53%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$10.00K -$10.00K
YoY Change 0.0%
Income Tax
% Of Pretax Income
Net Earnings -$5.563K $5.322K
YoY Change -204.53%
Net Earnings / Revenue -144.49%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.000M shares 4.500M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents $1.460K $238.00
Short-Term Investments
Other Short-Term Assets $0.00 $10.00K
YoY Change -100.0%
Inventory $0.00
Prepaid Expenses $1.936K
Receivables
Other Receivables
Total Short-Term Assets $3.396K $10.00K
YoY Change -66.04%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $33.05K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $33.05K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.396K $10.00K
Total Long-Term Assets $33.05K $0.00
Total Assets $36.44K $10.00K
YoY Change 264.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $169.00
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.47K $30.00K
YoY Change 51.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $45.47K $30.00K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $45.47K $30.00K
YoY Change 51.57%
SHAREHOLDERS EQUITY
Retained Earnings $39.09K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.028K -$15.30K
YoY Change
Total Liabilities & Shareholders Equity $36.44K $10.00K
YoY Change 264.42%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$5.563K $5.322K
YoY Change -204.53%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities $10.00K -$10.00K
YoY Change -200.0%
INVESTING ACTIVITIES
Capital Expenditures $20.00K $10.00K
YoY Change 100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$20.00K -$10.00K
YoY Change 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.00K 10.00K
YoY Change 100.0%
NET CHANGE
Cash From Operating Activities 10.00K -10.00K
Cash From Investing Activities -20.00K -10.00K
Cash From Financing Activities 20.00K 10.00K
Net Change In Cash 10.00K -10.00K
YoY Change -200.0%
FREE CASH FLOW
Cash From Operating Activities $10.00K -$10.00K
Capital Expenditures $20.00K $10.00K
Free Cash Flow -$10.00K -$20.00K
YoY Change -50.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001885849
dei Amendment Flag
AmendmentFlag
false
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q1 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-260430
dei Entity Registrant Name
EntityRegistrantName
TOFLA MEGALINE INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1911358
dei Entity Address Address Line1
EntityAddressAddressLine1
Manzanillo 33. Local E, Col. Roma Norte
dei Entity Address City Or Town
EntityAddressCityOrTown
Mexico
dei Entity Address Country
EntityAddressCountry
MX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06700
dei City Area Code
CityAreaCode
52
dei Local Phone Number
LocalPhoneNumber
5541607366
dei Contact Personnel Email Address
ContactPersonnelEmailAddress
[email protected]
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5352035 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1460 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1936 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2920 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3396 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
3356 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33046 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14128 usd
CY2023Q1 us-gaap Assets
Assets
36442 usd
CY2022Q3 us-gaap Assets
Assets
17484 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
169 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
45301 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
42544 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
45470 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
42544 usd
CY2023Q1 us-gaap Liabilities
Liabilities
45470 usd
CY2022Q3 us-gaap Liabilities
Liabilities
42544 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5352035 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5352035 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4500000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4500000 shares
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
5352
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
4500
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24709 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39089 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
29560 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9028 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25060 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36442 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17484 usd
CY2023Q1 us-gaap Revenues
Revenues
3850 usd
us-gaap Revenues
Revenues
6950 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3398 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3336 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6913 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14536 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2221 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
526 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3582 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
726 usd
CY2023Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3794 usd
CY2022Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1460 usd
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
5985 usd
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1460 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
9413 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
5322 usd
us-gaap Operating Expenses
OperatingExpenses
16480 usd
us-gaap Operating Expenses
OperatingExpenses
16722 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5563 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5322 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
9530 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
16722 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5563 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5322 usd
us-gaap Net Income Loss
NetIncomeLoss
9530 usd
us-gaap Net Income Loss
NetIncomeLoss
16722 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000264 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4954605 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4500000 shares
CY2021Q3 us-gaap Shares Issued
SharesIssued
4500000 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1421 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-11400 usd
CY2021Q4 us-gaap Shares Issued
SharesIssued
4500000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-9979 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5322 usd
CY2022Q1 us-gaap Shares Issued
SharesIssued
4500000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-15301 usd
CY2022Q3 us-gaap Shares Outstanding
SharesOutstanding
4500000 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-25060 usd
CY2022Q4 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
238301 shares
CY2022Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7149 shares
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-3966 usd
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
4738301 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-21877 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
613734 shares
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18412 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5563 usd
CY2023Q1 us-gaap Shares Outstanding
SharesOutstanding
5352035 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9028 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
9530 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
16722 usd
us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
3582 usd
us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
726 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-985 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4174 usd
us-gaap Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
39 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
169 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4794 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20209 usd
us-gaap Indefinite Lived Intangible Assets Purchase Accounting Adjustments
IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
22500 usd
us-gaap Indefinite Lived Intangible Assets Purchase Accounting Adjustments
IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
6325 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
22500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6325 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25561 usd
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
3100 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
5857 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
22672 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28318 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22672 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1024 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3862 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4100 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1460 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238 usd
us-gaap Profit Loss
ProfitLoss
9530 usd
CY2023Q1 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
39089 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zBKXtmlKWguk" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_zckADEylqhi5">Use of Estimates</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: center">10<br/> </p>
us-gaap Property Plant And Equipment Preproduction Design And Development Costs
PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts
6,325
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33046 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14128 usd
us-gaap Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure
RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure
<p id="xdx_84F_eus-gaap--RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_zYzxVQYm5KS6" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_868_zlgkTPpA7cF3">Revenue Recognition</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers”. The core principle of ASC 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. An entity recognizes revenue in accordance with that core principle by applying the following steps: Step 1: Identify the contract with the customer. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price. Step 4. Allocate the transaction price. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s revenues are recognized at a point-in-time as ownership of software (when it is approved by the customer) is transferred at a distinct point in time per the terms of a contract. The Company shall not be liable for any failure to perform its obligations if such failure is due to circumstances beyond its reasonable control. Any liability of the Company shall be limited to the total of all amounts paid by the customer for services under the contract.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: center">12<br/> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company plans to collect payment from customers prior to transferring ownership of the software and may require deposits from customers at the time an order is placed. When deposits are collected prior to transferring ownership of the software the Company recognizes deferred revenue until the transfer is made. During the six months ended January 31, 2023 and 2022, the Company’s revenue was $<span id="xdx_906_eus-gaap--RevenuesExcludingInterestAndDividends_c20220801__20230131_zUVZfwwrIUO5" title="revenue">6,950</span> and $0, respectively. As of January 31, 2023 and July 31, 2022 the Company had no deferred revenue.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
6950 usd
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5352035 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4500000 shares
CY2023Q1 us-gaap Advances Fair Value Disclosure
AdvancesFairValueDisclosure
45301 usd

Files In Submission

Name View Source Status
0001885849-23-000004-index-headers.html Edgar Link pending
0001885849-23-000004-index.html Edgar Link pending
0001885849-23-000004.txt Edgar Link pending
0001885849-23-000004-xbrl.zip Edgar Link pending
cer31.htm Edgar Link pending
cer32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
none-20230131.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tofla10q_31012023.htm Edgar Link pending
none-20230131_def.xml Edgar Link unprocessable
none-20230131_cal.xml Edgar Link unprocessable
none-20230131_lab.xml Edgar Link unprocessable
none-20230131_pre.xml Edgar Link unprocessable
tofla10q_31012023_htm.xml Edgar Link completed